125 related articles for article (PubMed ID: 2413196)
1. Urinary excretion characteristics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate.
Takakura Y; Kato A; Hashida M; Honda K; Arimoto A; Satomura K; Sezaki H
J Pharmacobiodyn; 1985 May; 8(5):357-64. PubMed ID: 2413196
[TBL] [Abstract][Full Text] [Related]
2. Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran.
Hashida M; Atsumi R; Nishida K; Nakane S; Takakura Y; Sezaki H
J Pharmacobiodyn; 1990 Jul; 13(7):441-7. PubMed ID: 1705289
[TBL] [Abstract][Full Text] [Related]
3. Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat.
Hashida M; Kato A; Takakura Y; Sezaki H
Drug Metab Dispos; 1984; 12(4):492-9. PubMed ID: 6148218
[TBL] [Abstract][Full Text] [Related]
4. Enhanced lymphatic delivery of mitomycin C conjugated with dextran.
Takakura Y; Matsumoto S; Hashida M; Sezaki H
Cancer Res; 1984 Jun; 44(6):2505-10. PubMed ID: 6202398
[TBL] [Abstract][Full Text] [Related]
5. Cellular interaction and in vitro antitumor activity of mitomycin C-dextran conjugate.
Matsumoto S; Yamamoto A; Takakura Y; Hashida M; Tanigawa N; Sezaki H
Cancer Res; 1986 Sep; 46(9):4463-8. PubMed ID: 2425952
[TBL] [Abstract][Full Text] [Related]
6. Disposition of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the perfused rat liver.
Sato K; Itakura K; Nishida K; Takakura Y; Hashida M; Sezaki H
J Pharm Sci; 1989 Jan; 78(1):11-6. PubMed ID: 2468759
[TBL] [Abstract][Full Text] [Related]
7. Disposition characteristics of mitomycin C-dextran conjugate in normal and tumor-bearing muscles of rabbits.
Atsumi R; Endo K; Kakutani T; Takakura Y; Hashida M; Sezaki H
Cancer Res; 1987 Nov; 47(21):5546-51. PubMed ID: 2444332
[TBL] [Abstract][Full Text] [Related]
8. Disposition and tumor localization of mitomycin C-dextran conjugates in mice.
Takakura Y; Takagi A; Hashida M; Sezaki H
Pharm Res; 1987 Aug; 4(4):293-300. PubMed ID: 2470072
[TBL] [Abstract][Full Text] [Related]
9. Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin C.
Kojima T; Hashida M; Muranishi S; Sezaki H
J Pharm Pharmacol; 1980 Jan; 32(1):30-4. PubMed ID: 6102123
[TBL] [Abstract][Full Text] [Related]
10. The accumulation mechanism of cationic mitomycin C-dextran conjugates in the liver: in-vivo cellular localization and in-vitro interaction with hepatocytes.
Nakane S; Matsumoto S; Takakura Y; Hashida M; Sezaki H
J Pharm Pharmacol; 1988 Jan; 40(1):1-6. PubMed ID: 2452868
[TBL] [Abstract][Full Text] [Related]
11. Preparation and properties of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate.
Noguchi A; Takahashi T; Yamaguchi T; Kitamura K; Takakura Y; Hashida M; Sezaki H
Bioconjug Chem; 1992; 3(2):132-7. PubMed ID: 1381223
[TBL] [Abstract][Full Text] [Related]
12. [Topical application of mitomycin C conjugated with dextran (MMC-D): a high molecular weight derivative of mitomycin C].
Honda K; Satomura K; Hashida M; Sezaki H
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):530-5. PubMed ID: 2408576
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection.
Nomura T; Saikawa A; Morita S; Sakaeda Kakutani T; Yamashita F; Honda K; Takakura Y; Hashida M
J Control Release; 1998 Mar; 52(3):239-52. PubMed ID: 9743445
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of a monoclonal antibody (HI30)-mitomycin C conjugate utilizing dextran T-40 and its specific cytotoxicity against human leukemia cell line CEM].
Zhu Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Aug; 12(4):274-80. PubMed ID: 1701360
[TBL] [Abstract][Full Text] [Related]
16. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Takahara J; Machida Y; Nagai T
Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
[TBL] [Abstract][Full Text] [Related]
17. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver.
Nishida K; Mihara K; Takino T; Nakane S; Takakura Y; Hashida M; Sezaki H
Pharm Res; 1991 Apr; 8(4):437-44. PubMed ID: 1714579
[TBL] [Abstract][Full Text] [Related]
18. Absorption characteristics of the lipophilic prodrug of mitomycin C from injected liposomes or an emulsion.
Sasaki H; Kakutani T; Hashida M; Sezaki H
J Pharm Pharmacol; 1985 Jul; 37(7):461-5. PubMed ID: 2863347
[TBL] [Abstract][Full Text] [Related]
19. Distribution and excretion of 7-N-(p-hydroxyphenyl)-mitomycin C in normal mice.
Imai R; Morimoto M; Marumo H
Gan; 1982 Aug; 73(4):675-80. PubMed ID: 6818093
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
Song Y; Onishi H; Nagai T
Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
